---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-000042"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2022-01-03T23:59:59+00:00"
generated_at: "2026-06-27T21:20:12.004645+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical appoints Scott Neils as interim CFO; Greg Jensen departs effective Jan 3, 2022

## Summary
- Greg Jensen, VP Finance and CFO, terminated effective January 3, 2022.
- Scott Neils, previously Controller since August 2019, appointed Interim CFO.
- Neils receives $300,000 base salary, 35% target bonus, 109,164 options and 88,983 RSUs.
- Jensen expected to enter standard separation agreement with severance per employment contract.

## SEC filing metadata
- accession: 0001493152-22-000042
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2022-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-000042
- JSON: https://secwatch.observer/filing/0001493152-22-000042.json
- Plain text: https://secwatch.observer/filing/0001493152-22-000042.txt

## Key facts
- Executive change
  Scott Neils was appointed as Interim Chief Financial Officer at Xtant Medical Holdings, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: announced the appointment of Scott Neils as Interim Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm
- Executive change
  Greg Jensen was terminated as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, Inc..
  - Action: terminated
  - Role: Vice President, Finance and Chief Financial Officer
  source text: whose employment terminated effective as of January 3, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.